Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

Aydin D., Bilici A., Yavuzer D., KEFELİ U., Tan A., Ercelep O., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.17, sa.8, ss.604-611, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Konu: 8
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s12094-015-1283-1
  • Sayfa Sayıları: ss.604-611


A disintegrin and metalloproteinase (ADAM) 17 has been indicated to be an indispensable regulator of cellular events from proliferation to migration. Although prognostic importance of ADAM17 expression has been investigated in several tumours, its clinical utility as a useful prognostic molecular marker remains unclear in gastric cancer. In the current study, we evaluated the expression of ADAM17 and its prognostic significance in gastric cancer patients after curative gastrectomy.